Skip to main content

Lansing Taylor

Premium
Lansing Taylor has been awarded this year’s Society for Biomolecular Sciences Accomplishment Award for his work on the commercialization of high-content screening technology, SBS said this week.
 
Taylor is the founder, president, and CEO of systems biology firm Cellumen. He was also the founder, chairman, president, and CEO of Cellomics, now a part of Fisher Biosciences.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.